During the past decade, Care Access Research, San Pablo conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 11 clinical trials were completed, i.e. on average, 39.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Care Access Research, San Pablo" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Shire" with 5 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Care Access Research, San Pablo" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Care Access Research, San Pablo" are "Ulcerative Colitis" (9 trials), "Crohn's Disease" (8 trials), "Myasthenia Gravis" (3 trials), "Alzheimer's Disease" (2 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Care Access Research, San Pablo" in a lesser frequency.

Most popular intervention types in "Care Access Research, San Pablo" are "Drug" (24 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Etrasimod" (4 trials), "Mirikizumab" (4 trials), "Ontamalimab" (4 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Care Access Research, San Pablo" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Care Access Research, San Pablo". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Care Access Research, San Pablo, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Care Access Research, San Pablo, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".